Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003 : Original article  

Involvement of glucose regulated stress protein of Mr 78kDa (GRP78), topoisomerase IIa in poly(ADP-ribose) mediated response to DNA damage inflicted by anti-cancer agents

S. Chatterjee

Med Sci Monit 2003; 9(1): 11-0 :: ID: 15057

Abstract

Poly(ADP-ribose)-deficient cell lines, developed by us, showed hypersensitivity to all the alkylating and platinating agents, UV, X-ray, and their mimetics. In contrast, they were extremely resistant to various kinds of topoisomeraseIIa inhibitors such as VP-16, adriamycin, and merbarone. We were bewildered by the fact that why poly(ADP-ribose) deficiency would result in hypersensitivity to certain classes of DNA damaging agents while developing resistance to others. We argued that since PARP and NAD+ serve as a stress-responsive system their absence could lead to the induction of another stress protein families. Indeed, we discovered that absence of poly(ADP-ribose) caused many-fold increase in GRP78 level with concomitant, significantly, attenuated level of topoisomeraseIIa. In subsequent experiments, using various approaches to induce GRP78, we showed that induction of GRP78 was associated with a significant decrease in both the level and activity of topoisomerase IIa which was sufficient to explain why poly(ADP-ribose)-deficient cells were resistant to topoisomeraseIIa inhibitors. In another set of experiments, using topoisomeraseIIa-deficient/dysfunctional cell lines and GRP78 overexpressed cell lines, we showed that topoisomeraseIIa was required for the repair of DNA damage inflicted by various alkylating and platinating agents and X-rays. Combining all these observations we propose the following pathway.Deficiency of poly(ADP-ribose) –> Overexpression of GRP78 –> Down-regulation of topoisomerase IIa –> Interference with DNA repair –> Sensitivity or resistance to DNA damaging agents.However, with a cautionary note, we suggest the existence of many more different pathways, which may not be mutually exclusive, that can account for the role of poly(ADP-ribose) in DNA repair. References: 1.Chatterjee S, Berger NA: Poly(ADP-ribose) polymerase in response to DNA damage. In: Nicoloff JA, Hoekstra M (Eds): DNA Damage and Repair: Vol 2, DNA Repair in Higher Eucaryotes. Chapter 22, Humana Press Inc. 1998, 487-515 2.Hirota H, Gosky D, Berger SJ, Berger NA, Chatterjee S: Interference with topoisomerase IIa potentiates melphalan cytotoxicity. Int J Oncology, 2002; 20: 311-318 3.Chatterjee S: Resistance or sensitivity to anti-cancer drugs: An emerging arena involving stress protein GRP78. Recent Research Developments in Cancer (Vol 4), 2002; 161-176 4.Gosky D, Chatterjee S: Down-regulation of topoisomerase IIa is caused by up-regulation of GRP78. Biochem Biophys Res Commun, 2003; 300: 327-332

Keywords: PARP, Poly(ADP-ribose), Topoisomerase IIa, GRP78, resistance or sensitivity to anticancer agents

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750